Gitte Pedersen

Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial

Casper Steenholdt, Jørn Brynskov, Ole Østergaard Thomsen et al. · Gut · 2013 · 454 citations

Medicine, Clinical Sciences, Pharmacotherapy +17

Tumour necrosis factor α converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease

Jørn Brynskov, Pia Foegh, Gitte Pedersen et al. · Gut · 2002 · 196 citations · Full text

Life Sciences, Immunology, Pathobiology +17

Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium

Gitte Pedersen, Lars Andresen, Mads Wichmann Matthiessen et al. · Clinical & Experimental Immunology · 2005 · 128 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

The Scandinavian Propaten® Trial – 1-Year Patency of PTFE Vascular Prostheses with Heparin-Bonded Luminal Surfaces Compared to Ordinary Pure PTFE Vascular Prostheses – A Randomised Clinical Controlled Multi-centre Trial

Jes S. Lindholt, B. Gottschalksen, Niels Johannesen et al. · European Journal of Vascular and Endovascular Surgery · 2011 · 119 citations · Full text

Medicine, Surgery, Prosthetics +3

Subintimal angioplasty as a treatment of femoropopliteal artery occlusions

E. Laxdal, Guttorm Jenssen, Gitte Pedersen et al. · European Journal of Vascular and Endovascular Surgery · 2003 · 105 citations · Full text

Medicine, Cardiology, Surgery +12